List of drug discovery products

Novartis is a healthcare and pharmaceutical company based in Basel, Switzerland, incorporated in 1996.

An artificial Intelligence company with a platform that acts as a search engine and holds summaries of scientific research papers. It is located in London, England and was founded in 2013.

ONI is a Super-Resolution Microscopy founded in 2016.

The company deals in the import and export of pharmaceuticals including cytostatics, antibiotics, hormones, vaccines, blood products and veterinary pharmaceuticals, bridging the delays in initial drug registrations and in case of supply shortages in certain markets.

Substance or compound that is added to a system in order to bring about a chemical reaction, or added to see if a reaction occurs

Elisa kits for research and diagnostic uses.

Pollenosis preventive product

Efficacy of il-10 was found by oral administration of allergic model mouse.

Gene expression analysis for eucaryote and procaryote.

Anti-cancer drug for solid tumors

Drug development project by obtaining autoantibodies of patients from tumor infiltration b cells

Research tool used for drug discovery and chemical biology research

The only commercially available scaffold-free bio 3d printer

Comprehensive labeling of cell surface molecular clustering in living cells, developed by kochi university

Antibacterial properties, product deployment of the biomass plastic film which it had in accordance with the antioxidant functio

Tms-007 is a novel stroke therapeutic drug candidate with dual mode of action, thrommbolysis and cerebroprotection.

Supply for the synthesis of bna oligonucleotides

The new technology of immunopotentiation for large animals

Target: critical limb ischemia

Rotating culture device dedicated to octagonal cell culture bottles. can be used in the incubator. please order with the bottle.

HLA-A02 restricted cancer peptide vaccine

Oncolytic adeno virus which is expected to induce immune response against cancer

Prevention of gvhd in patients with hematological malignancies undergoing ahsct